Xavier Loyer Selected Research

Xavier Loyer Research Topics

Disease

9	Atherosclerosis 01/2019 - 03/2013
8	Inflammation (Inflammations) 01/2020 - 01/2014
7	Myocardial Infarction 01/2020 - 10/2004
5	Heart Failure 01/2016 - 10/2004
4	Cardiomegaly (Heart Hypertrophy) 01/2020 - 10/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 03/2013
3	Ischemia 01/2020 - 08/2011
3	Hypertrophy 07/2019 - 04/2008
3	Abdominal Aortic Aneurysm 07/2019 - 10/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 03/2013
3	Diabetic Cardiomyopathies 01/2017 - 09/2007
3	Heart Diseases (Heart Disease) 05/2013 - 10/2007
2	Fibrosis (Cirrhosis) 01/2020 - 12/2019
2	Aneurysm (Aneurysms) 01/2017 - 10/2013
1	Obesity 06/2021
1	Neoplasms (Cancer) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Reperfusion Injury 01/2020
1	Cicatrix (Scar) 01/2020
1	Hypoxia (Hypoxemia) 12/2019
1	Hypercholesterolemia 07/2017
1	Atherosclerotic Plaque (Atheroma) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Infarction (Infarctions) 01/2016
1	Chronic Limb-Threatening Ischemia 11/2014
1	Aortic Rupture 10/2013
1	Rupture 10/2013
1	Cardiomyopathies (Cardiomyopathy) 12/2008
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2006

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 07/2019 - 01/2012
5	Apolipoproteins E (ApoE)IBA 01/2019 - 02/2015
4	Biological ProductsIBA 01/2021 - 01/2014
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017 - 10/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
3	CytokinesIBA 01/2020 - 01/2014
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 07/2019 - 10/2004
3	Nitric Oxide Synthase (NO Synthase)IBA 07/2019 - 09/2007
3	Protein Isoforms (Isoforms)IBA 07/2019 - 10/2007
3	Angiotensin IIIBA 01/2017 - 10/2013
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017 - 09/2007
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2008 - 10/2004
2	Pharmaceutical PreparationsIBA 01/2021 - 09/2015
2	Long Noncoding RNAIBA 01/2020 - 12/2019
2	ApolipoproteinsIBA 01/2019 - 07/2017
2	Interleukin-10 (Interleukin 10)IBA 07/2017 - 10/2013
2	LDL Receptors (LDL Receptor)IBA 07/2017 - 03/2013
1	AdipokinesIBA 06/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	alpha2 Subunit Collagen Type IIBA 01/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 07/2019
1	CalcineurinIBA 07/2019
1	Proteins (Proteins, Gene)FDA Link 07/2019
1	Leucine (L-Leucine)FDA Link 07/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Atorvastatin (Lipitor)FDA Link 01/2017
1	Peptides (Polypeptides)IBA 12/2016
1	nangibotideIBA 12/2016
1	LipidsIBA 11/2016
1	alpha minimal essential mediumIBA 01/2016
1	lipid phosphate phosphataseIBA 07/2015
1	Phosphatidate PhosphataseIBA 07/2015
1	lysophosphatidic acidIBA 07/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2015
1	Therapeutic UsesIBA 04/2015
1	AntagomirsIBA 04/2015
1	Lewis X AntigenIBA 11/2014
1	Becaplermin (PDGF-BB)FDA Link 11/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2014
1	Kruppel-Like Factor 4IBA 01/2014
1	oxidized low density lipoproteinIBA 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2014
1	Monoclonal AntibodiesIBA 10/2013
1	Mitogen-Activated Protein KinasesIBA 05/2013
1	varespladib methylIBA 03/2013
1	varespladibIBA 03/2013
1	EnzymesIBA 03/2013
1	Secretory Phospholipases A2IBA 03/2013
1	Small Untranslated RNAIBA 08/2011
1	OxidesIBA 12/2008
1	phospholambanIBA 10/2008
1	CalciumIBA 06/2008
1	Tissue Kallikreins (Tissue Kallikrein)IBA 04/2008
1	Estrogens (Estrogen)FDA Link 10/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2007
1	Annexin A5IBA 01/2006
1	AnnexinsIBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2016 - 10/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Secondary Prevention 01/2017
1	Injections 01/2016
1	Aftercare (After-Treatment) 11/2014